Introduction {#section1-1179546817751438}
============

End-stage heart failure (HF), which is medically intractable, became an important problem in the setting of HF. In such cases, heart transplantation is a radical cure, and left ventricular assist device (LVAD) is another helpful support and used as either a bridge to heart transplantation or destination therapy. However, the sources of these surgical therapies were limited so that inotrope support is easily used to maintain the flow to vital organs as a bridge or alternate to the surgical interventions.^[@bibr1-1179546817751438]^ The use of inotrope might sometimes lead to the correction of appropriate hemodynamic balance, resulting in the weaning off of inotrope agents, whereas the state of inotrope dependency could not be taken off in some cases. There was little epidemiologic data about the dependency of inotrope; however, there are many opportunities of the use of inotrope in various clinical settings. However, the discussion about the efficacy of inotropic agents had not led to definitive conclusions because of lacking well-designed investigations that were practically difficult.^[@bibr2-1179546817751438],[@bibr3-1179546817751438]^ In addition, the continuous inotropic infusion therapy could have various influences, such as suppressing the physical activities, leading to skeletal muscle atrophy, which might aggravate the course of HF.

Several reports discuss the effect of exercise-based rehabilitation programs for patients with New York Heart Association (NYHA) class I to III HF.^[@bibr4-1179546817751438],[@bibr5-1179546817751438]^ However, there is little evidence about the effect of cardiac rehabilitation (CR) for patients with more severe HF. Recently, several studies investigated the effect of exercise in patients with left ventricle (LV) dysfunction and subsequent improvements in exercise capacity without an adverse effect on LV remodeling or other serious complications.^[@bibr3-1179546817751438]^ Rather than having a detrimental effect, exercise was reported to decrease abnormal remodeling in cases of HF with impaired LV function.^[@bibr4-1179546817751438]^ However, studies that investigated the effect of exercise in patients with HF excluded patients with NYHA class IV, those who were hemodynamically unstable, or those who received continuous inotropic agents.^[@bibr6-1179546817751438]^ Whether exercise training should be avoided until stabilization of HF has not been clearly elucidated yet. On the other hand, delayed CR significantly affects fitness outcomes.^[@bibr7-1179546817751438]^ For every 1 day of waiting time for instituting CR, patients are 1% less likely to show improvement across all fitness-related measures.^[@bibr7-1179546817751438]^

In particular, patients who were dependent on inotropic agents were the most problematic. Inotropic agents such as dobutamine are used for acute or subacute decompensation of HF due to severely impaired cardiac output, or these agents are used for hemodynamic support as a pharmacologic bridge to a more definitive intervention such as a ventricular assist device or cardiac transplantation. Inotrope dependence means that withdrawal of inotropes leads to symptomatic hypotension, recurrent congestive symptoms, or worsening renal function.^[@bibr8-1179546817751438]^ As a result, the duration of continuous dobutamine infusion is highly variable; if used for a long period of time, exercise restriction may worsen the atrophic change of skeletal muscle and decrease the adaptive response to exercise. These detrimental effects may easily aggravate the course of HF itself.

In this review, we summarize the methodology of exercise training in stable patients with advanced HF receiving continuous inotropic agents, which can be represented by the patients with the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile 3 in other words.

Pathophysiological Change in Advanced HF {#section2-1179546817751438}
========================================

In patients with advanced HF, there are much systemic influences, which affect the course of HF. One important site affected by the presence of HF is skeletal muscle and it has been reported to be abnormal. A change in size of skeletal muscle fiber or type was detected in one study.^[@bibr9-1179546817751438]^ An anabolic/catabolic imbalance affects muscle loss as a result of reduced muscle anabolism, increased muscle catabolism, or both.^[@bibr10-1179546817751438]^ In addition, muscle consists of slow-twitch type I and fast-twitch type II muscle fibers, and the fiber type distribution was distributed toward type II fibers in patients with HF; their capillary length density of skeletal muscle was also reduced.^[@bibr9-1179546817751438]^ These intrinsic alterations of skeletal muscle are the main contributors of limited exercise capacity in patients with HF. These skeletal muscle abnormalities are often complicated in cases of severe HF. In addition, the patient's condition sometimes worsens to cardiac cachexia. Cardiac cachexia is characterized by increase in inflammatory cytokine and neuroendocrine factors, such as tumor necrosis factor α, norepinephrine, and cortisol; muscle wasting; and loss of muscle protein.^[@bibr11-1179546817751438]^ The presence of skeletal myopathy and cardiac cachexia suggests a poor prognosis in patients with HF. For instance, reduced muscle mass or muscle power suggests poor prognosis in HF patients undergoing ventricular assist device placement.^[@bibr12-1179546817751438]^ Therefore, prevention of these complications may improve the course of HF and become one critical target of HF therapy in the clinical viewpoint.^[@bibr13-1179546817751438][@bibr14-1179546817751438]--[@bibr15-1179546817751438]^ However, it remains unknown how suppression of the pathways leading to skeletal myopathy or cardiac cachexia contributes to reduce risk of HF or increase the survival rate.

According to vascular function, endothelial dysfunction and increased vascular tone were also complicated with HF and these complications further worsened the hemodynamic compromise in HF.^[@bibr16-1179546817751438]^ The decrease in endothelial dysfunction in patients with HF complicates the coordination of hemodynamic compromise, leading to increased mortality and worse prognosis.^[@bibr17-1179546817751438]^ Increased vascular tone, which is mediated by several pathways, such as autonomic nerve system or renin-angiotensin pathways, also becomes a burden to the compromised hemodynamics in HF.^[@bibr18-1179546817751438]^

Beneficial or Evil Effects of Inotrope Agents on Exercise in Advanced HF {#section3-1179546817751438}
========================================================================

Few published reports discuss exercise in patients receiving continuous inotropic support.^[@bibr19-1179546817751438],[@bibr20-1179546817751438]^ The safety and efficacy of exercise training in patients with intravenous inotropic support have been described; however, there is insufficient evidence for the benefits of exercise training in this setting because of the small numbers of subjects included in the studies. According to the safety, the appropriate assessments for the feasibilities of exercise training significantly reduce the risk of exercise training for patients with inotropic infusion who were awaiting for heart transplantation. However, more critical evaluation of exercise training for these patients should be performed by longer follow-up duration. Indeed, several reports on exercise training in patients with advanced HF showed unchanged exercise capacity.^[@bibr21-1179546817751438]^ The ability to perform exercise testing itself means a capacity for maintained exercise. By contrast, there are little data on the effect of exercise training in patients with severely impaired exercise capacity, those who are dependent on continuous inotropic support, or those who are unable to perform exercise testing.

The physiology of dobutamine infusion results in an efficient reduction in pulmonary wedge pressure with a mild increase in heart rate,^[@bibr22-1179546817751438]^ lowering the risk of worsening HF during exercise. Milrinone (phosphodiesterase inhibitor) infusion, another commonly used inotrope, also has similar beneficial effects on exercise.^[@bibr3-1179546817751438]^ In addition, milrinone has another pleiotropic effect and suppresses the inflammatory cytokines, such as tumor necrosis factor or interleukin 8, which are increased in patients with HF.^[@bibr23-1179546817751438]^ In contrast, arrhythmic events reportedly increased during inotropic infusion.^[@bibr24-1179546817751438]^ However, the effect of inotropic agents' infusion on exercising skeletal muscle was described previously, demonstrating that the increased cardiac output and blood flow to limbs does not necessarily improve oxygen delivery to working skeletal muscle in patients with HF.^[@bibr25-1179546817751438],[@bibr26-1179546817751438]^ In another study, a metabolic change in skeletal muscle occurred during inotropic infusion and it increased glucose production and uptake to adapt higher levels of muscular carbohydrate use during exercise.^[@bibr27-1179546817751438],[@bibr28-1179546817751438]^ In addition, β-adrenergic signaling has been proposed as an important regulator of skeletal muscle regenerations and it may have some effects on the increase in skeletal muscle mass through its anabolic properties.^[@bibr29-1179546817751438],[@bibr30-1179546817751438]^ Among β-agonists, β~2~-adrenergic pathway had been reported to have beneficial impact on skeletal muscle.^[@bibr31-1179546817751438]^ Indeed, β~2~-adrenergic agonists can change the composition of skeletal muscle fiber type and increase maximal isometric force production.^[@bibr32-1179546817751438],[@bibr33-1179546817751438]^ There are several reports demonstrating that β-agonists can exert a protective effect on skeletal muscle in patients with HF by antagonizing the protein degradation associated with cachexia.^[@bibr34-1179546817751438]^ Histologically, β~2~-agonists induced hypertrophy of fast-twitch muscles, resulting in slow to fast alterations in skeletal muscle fibers.^[@bibr35-1179546817751438]^ Dobutamine has some effects through β~2~-receptor as compared with dopamine^[@bibr36-1179546817751438]^ so that dobutamine may have some powers against muscle wasting through β~2~-pathways. By contrast, dopamine also has powers of increasing skeletal muscle mass through dopamine receptor.^[@bibr37-1179546817751438]^ These protective effects have been associated with an inhibition of proteolysis (calcium-dependent proteolysis and adenosine triphosphate--dependent proteolysis) and an activation of protein synthesis signaling pathways,^[@bibr38-1179546817751438]^ whereas milrinone may have negative impact on skeletal muscle contractility.^[@bibr39-1179546817751438]^ However, there had been no clinical data about the comparison of the effect of catecholamine infusion on skeletal muscle.

According to the vascular function and autonomic nerve balance, there reported to be some effects by dobutamine infusion.^[@bibr40-1179546817751438]^ Freimark et al^[@bibr41-1179546817751438]^ demonstrated dobutamine infusion beneficially affected endothelial function that may have a beneficial effect on exercise. Al-Hesayen et al^[@bibr40-1179546817751438]^ reported that dobutamine infusion caused a significant sympatholytic response in patients with HF unexpectedly, other than sympathoexcitatory effects. The comparative study of dopamine and dobutamine demonstrated that both have comparable therapeutic effects in patients with HF; however, low-dose dopamine had more favorably affects cardiac autonomic function.^[@bibr42-1179546817751438]^ Dopamine even restored the depressed circadian change in patients with HF. By these effects, exercise training may be induced with ease or reducing its risk. However, little was found about the association between exercise and dobutamine or milrinone infusion.

Consideration of the Start of Rehabilitation {#section4-1179546817751438}
============================================

Prescribing exercise in critically hemodynamically unstable patients enhances the risk of exercise more than its benefit. The appropriate timing to initiate exercise training has been poorly investigated and described.^[@bibr43-1179546817751438],[@bibr44-1179546817751438]^ The state of continuous inotropic infusion has been cited as an increased risk for exercise training, not as a contraindication.^[@bibr43-1179546817751438]^ However, once the decompensation of HF is stabilized even with using inotropic agents, exercise training can be initiated at a very low level of intensity. One example of exercise protocol regimen is presented in [Figure 1](#fig1-1179546817751438){ref-type="fig"}. Indeed, a consensus document of the HF Association and the European Association for Cardiovascular Prevention and Rehabilitation mentions that early mobilization through an individualized exercise program may prevent further disability after hospitalization due to HF.^[@bibr43-1179546817751438]^ In addition, just 1 week is sufficient to start substantial muscle atrophy and induce whole-body insulin resistance in the absence of skeletal muscle lipid accumulation.^[@bibr45-1179546817751438][@bibr46-1179546817751438]--[@bibr47-1179546817751438]^ To reduce the detrimental effect of bed rest, exercise training should be started as early as possible and balancing the risk and benefit of exercise is of utmost importance.

![The course of exercise training for patients with advanced heart failure. BNP indicates brain natriuretic peptide.](10.1177_1179546817751438-fig1){#fig1-1179546817751438}

The identification of clinical stability is most critical for the induction of exercise training and it is defined by stable symptoms, absence of resting symptoms and postural hypotension, stable fluid balance, freedom from evidence of congestion, stable renal function, and normal electrolyte value.^[@bibr48-1179546817751438]^ The level of B-type natriuretic peptide (BNP) also offers information about the clinical stability in HF treatment. BNP--guided decisions may reduce the risk of prescribing an exercise protocol too early; however, there is insufficient evidence for it.^[@bibr49-1179546817751438]^ Measuring the change of BNP can offer some information about clinical stability in HF.

Patients with INTERMACS profile 3, who are dependent on continuous inotropic support, may progress in a short time to the next stage of surgical HF therapies, such as an LVAD or heart transplantation. Exercise training before surgery may have the beneficial effect of reducing operative risk; however, there is no concise protocol regarding this. Early initiation of exercise training after implantation of an LVAD has been reported to be associated with improvements in exercise capacity.^[@bibr50-1179546817751438]^ Several reports support the effectiveness of exercise training after the implantation of VAD, but this discussion is beyond the scope of this article.^[@bibr51-1179546817751438]^

Methodology of Exercise Training in Patients With Advanced HF {#section5-1179546817751438}
=============================================================

The difficulty in this situation is uncertainty of appropriate exercise protocol. The appropriate intensity of exercise is generally determined by an exercise test; however, patients with severe HF cannot perform the exercise test at the initiation of training^[@bibr52-1179546817751438]^ because of their low exercise capacity and lack of conditioning.

Indeed, sufficient and effective exercise training protocols differ by the expected results of exercise training. For instance, high-intensity protocols promote superior improvements of VO~2~max,^[@bibr28-1179546817751438],[@bibr29-1179546817751438]^ whereas muscle mass, metabolic capacity, and proteasome activation were sufficiently improved by moderate-intensity exercise.^[@bibr30-1179546817751438]^ However, the most critical point in the initiation of CR in patients with severe HF is safety. Care must be taken especially with frail older populations because of the increased risk of adverse events, including injuries and falls, associated with exercise training.^[@bibr53-1179546817751438],[@bibr54-1179546817751438]^

Aerobic training of the lowest intensity still provides a training effect in cardiac patients with a markedly reduced exercise capacity.^[@bibr55-1179546817751438]^ Therefore, the lowest load of intensity (such as 10 W × 5-20 minutes) should be prescribed first and, as the exercise is tolerated, it should be increased gradually. Indeed, we certified that there was no case in which low-level and short-term (such as 5 minutes) ergometer exercise exacerbated the status of HF after appropriate screening for the candidate of exercise training in patients with inotropic infusion (unpublished data). In the absence of exercise tests, an exercise program can be developed using Borg scales and/or subjective tools such as the talk test.^[@bibr56-1179546817751438]^ A subjective rating of perceived exertion Borg scale rating of 9 to 12 should be sufficient for the patient to tolerate light to moderate exertion. The patient's heart rate response may also suggest the tolerability of exercise, and abrupt increase in heart rate after the initiation of exercise or dull normalization of heart rate after the termination of exercise may suggest intolerable excess exercise load and has to be carefully managed. According to the principles of endurance training, cycle ergometer training at the lowest intensity for 5 to 10 minutes may be tried with continuous electrophysiological monitoring and observing the response of vital signs to the prescribed load. A recumbent ergometer may have a hemodynamically milder load than an upright ergometer.^[@bibr57-1179546817751438]^ Each response to exercise should be monitored for abnormal responses, such as postexercise hypotension, atrial and ventricular arrhythmias, and worsening HF symptoms.

Resistance training can be safely used for training small muscle groups. Short bouts of work are applied, and the number of repetitions is limited.^[@bibr43-1179546817751438]^ In resistance training, small loads, such as those outlined in a pretraining protocol in a consensus document, should be performed first.^[@bibr43-1179546817751438]^ This type of resistance training is performed before the start of endurance training, and the intensities of endurance and resistance training are then increased with caution. Some reports conclude that resistance training may be more effective than aerobic training in attenuating or reversing skeletal muscle atrophy in patients with HF.^[@bibr58-1179546817751438]^

Interval training, which has characteristics of both endurance and resistance training, may be a promising method of exercise. Interval training can be defined as repeated bouts of short-duration, high-intensity exercise separated by brief periods of constant, lower-intensity work rate exercise. Indeed, interval training has been reported to improve skeletal muscle function in addition to exercise capacity; however, appropriate protocols have not been developed yet.^[@bibr59-1179546817751438],[@bibr60-1179546817751438]^ Recently, lactate ambulation induced by high-intensity interval training can lead to mitochondrial adaptations in skeletal muscle.^[@bibr61-1179546817751438]^ It may be helpful to begin with intermittent instead of continuous exercise in patients with severely impaired exercise capacity.

In addition to these protocols, electrical muscle stimulation (EMS) and inspiratory muscle training are other effective methods of rehabilitation for advanced HF. Indeed, several reports demonstrated the efficacy of EMS in patients with advanced HF.^[@bibr62-1179546817751438],[@bibr63-1179546817751438]^ For instance, Forestieri et al^[@bibr64-1179546817751438]^ demonstrated the improvement of exercise capacity in patients by EMS, and EMS demonstrated a significantly higher dose reduction in dobutamine infusion. By contrast, the addition of inspiratory muscle training was reported to improve quality of life in patients with HF.^[@bibr65-1179546817751438]^ However, there had been only insufficient evidence for these interventions. How these methods are added to regular aerobic exercise should be considered according to each individual case.

When exercise capacity improves up to the level in which walking in a short distance is available, 6-minute walk test is increasingly implemented to assess the exercise capacity.^[@bibr66-1179546817751438]^ Monitoring and coordination of physical activity using a pedometer step count may also be beneficial in the process of CR in HF.^[@bibr67-1179546817751438]^

Expected Results of Exercise Training {#section6-1179546817751438}
=====================================

Exercise training in CR is generally performed to improve exercise capacity. However, there are various expected results of exercise, and exercise training in patients with severe HF who are on continuous inotropic support should be approached in a different way. There were several studies dealing with the efficacies of exercise training on patients with moderately impaired cardiac function ([Table 1](#table1-1179546817751438){ref-type="table"}). Among them, there were little studies for patients with inotropic agents, and the effect derived from exercise training should be resumed by the reports of patients with reduced cardiac function, which are presented in [Table 1](#table1-1179546817751438){ref-type="table"}.

###### 

Clinical trials of exercise training that include patients with advanced heart failure.

![](10.1177_1179546817751438-table1)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author                               Patients                                        Ratio of DCM   Mean LVEF   N      Protocol                                                                                                                                                                        Duration   Effect                                                                                                    
  ------------------------------------------ ----------------------------------------------- -------------- ----------- ------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- --------------------------------------------------------------------------------------------------------- --------------------------------------------
  Selig^[@bibr68-1179546817751438]^          LVEF \< 40%, NYHA I-IV                          NA             27 ± 7      39     Leg cycling, elbow extension/flexion, stair climbing, arm cycling, knee extension/flexion, shoulder press/pull                                                                  3 mo       Peak VO~2~, skeletal muscle strength, HRV                                                                 *J Card Fail*. 2004:;21-30

  Belardinelli^[@bibr69-1179546817751438]^   LVEF \< 40%                                     15             28 ± 6      99     Leg cycling                                                                                                                                                                     14 mo      Peak VO~2~                                                                                                *Circulation*. 1999;99:1173-82

  Wisløff^[@bibr70-1179546817751438]^        Stable postinfarction heart failure             0              26 ± 8      27     10 min at ≈60% to 70% of peak heart rate + walking 4-min intervals at 90% to 95% of peak heart rate vs walking at 70% to 75% of peak heart rate                                 12 mo      Peak VO~2~, endothelial function, LVEF\                                                                   *Circulation*. 2007;115:3086-94
                                                                                                                                                                                                                                                                                                                          LV reverse remodeling                                                                                     

  Arad^[@bibr71-1179546817751438]^           Advanced CHF (NYHA III, stage D)                23             27 ± 4      30     45 min of exercise on a treadmill, a stair machine, a bicycle, targeting 60%-70% of the HRR                                                                                     18 wk      6-min walk, exercise duration, peak VO~2~, cardiac index, LVEF, pulmonary artery pressure                 *Int J Cardiol*. 2008:114-119

  Pu^[@bibr72-1179546817751438]^             NYHA I to III, LVEF ≤ 45%                       NA             36 ± 3      16     Dynamic contractions of the large upper- and lower-body muscle groups (seated leg press, chest press, knee extension, triceps and knee flexion)\                                12 wk      Skeletal muscle strength, 6-min walk                                                                      *J Appl Physiol*. 2001:2341-2350
                                                                                                                               5 exercises/3 sets/8 reps/80% of 1 RM                                                                                                                                                                                                                                                                

  Conraads^[@bibr73-1179546817751438]^       Stable HF                                       50             NA          23     RT (9 exercises/2 sets/6-10 reps/50% of 1 RM) + ET                                                                                                                              4 mo       Inflammatory marker, NYHA class, peak VO~2~                                                               *Eur Heart J*. 2002:1854-1860

  Maiorana^[@bibr74-1179546817751438]^       NYHA I to III                                   46             26 ± 3      13     Cycle ergometry, treadmill walking, and RT (7 exercises/1 set/12 reps/55%-65% of 1 RM)                                                                                          8 wk       Peak VO~2~ exercise test duration, ventilatory threshold                                                  *J Appl Physiol*. 2000:1565-1570

  O'Connor^[@bibr75-1179546817751438]^       NYHA II to IV, LVEF \< 35%                      51             25 ± 5      2331   15-30 min/session at an HR of 60% of HRR\                                                                                                                                       12 wk      Cardiovascular mortality↓ or heart failure hospitalization ↓                                              *JAMA*. 2009;301:1439-1450
                                                                                                                               After 6 sessions, 30-35 min, and 70% of HRR                                                                                                                                                                                                                                                          

  Erbs^[@bibr76-1179546817751438]^           NYHA IIIb                                       46             24 ± 2      37     3 to 6 times daily for 5 to 20 min on ergometer adjusted to 50% of VO~2max~ (3 wk) → training target HR for home training (HR at 60% of VO~2max~)                               12 wk      Peak VO~2~, LVEF, endothelial function, skeletal muscle capillary density                                 *Circulation: Heart Failure*. 2010:486-494

  Passino^[@bibr77-1179546817751438]^        LVEF \< 45%, peak VO~2~ \< 25 mL/min/kg         41             35 ± 2      85     For a minimum of 3 d/wk 30 min/d keeping HR at 65% of peak VO~2~ HR                                                                                                             9 mo       Peak VO~2~, LVEF, QoL, serum BNP level                                                                    *JACC*. 2006:1835-1839

  Scrutinio^[@bibr78-1179546817751438]^      Symptoms of HF for at least 6 mo, LVEF \< 40%   46             27 ± 6      275    Tailored low-intensity individual exercise program, consisting of respiratory, mobilization, musculoskeletal flexibility, movement coordination, and/or calisthenic exercises   NA         All-cause mortality, urgent heart transplantation at 1 y ↓                                                *J Cardiopulm Rehabil Prev*. 2012:71-77

  Gielen^[@bibr79-1179546817751438]^         NYHA II-III, LVEF \< 40%                        65             25 ± 2      20     4 to 6 times daily for 10 min on a bicycle ergometer\                                                                                                                           6 mo       Peak VO~2~, skeletal muscle inflammatory marker expression (TNF-α, IL-6, IL-1β)                           *JACC*. 2003:861-868
                                                                                                                               Workloads 70% of VO~2max~\                                                                                                                                                                                                                                                                           
                                                                                                                               After discharge, bicycle ergometers for daily home exercise training                                                                                                                                                                                                                                 

  Hambrecht^[@bibr80-1179546817751438]^      NYHA II-III, LVEF \< 40%                        89             26 ± 9      22     Supervised in hospital---home-based training\                                                                                                                                   6 mo       Peak VO~2~, peak leg oxygen consumption, changes in cytochrome c oxidase--positive mitochondria           *JACC*. 1995:1239-1249
                                                                                                                               ET (4-6 sessions/wk 10-60 min/session. 70% VO~2max~) + RT                                                                                                                                                                                                                                            

  Hambrecht^[@bibr81-1179546817751438]^      NYHA I-III, LVEF \< 40%                         84             27 ± 9      137    Supervised in hospital---home-based training\                                                                                                                                   6 mo       Heart rate, VO~2max~, VE~max~, total peripheral resistance                                                *JAMA*. 2000:3095-3101
                                                                                                                               ET (4-6 sessions/wk 10-60 min/session. 70% VO~2max~) + RT                                                                                                                                                                                                                                            

  Klocek^[@bibr82-1179546817751438]^         YHA II-III, LVEF \< 40%                         NA             34 ± 4      42     Group A with constant workload, group B with progressive/increasing workload                                                                                                    6 mo       Peak VO~2~, QoL score (cardiac symptom, emotional distress, peripheral circulatory symptoms, dizziness)   *Int J Cardiol*. 2005:323-329
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: BNP, brain natriuretic peptide; CHF, chronic heart failure; DCM, dilated cardiomyopathy; ET, endurance training; HF, heart failure; HR, heart rate; HRR, heart rate response; LVEF, left ventricular ejection fraction; NA, not applicable; NYHA, New York Heart Association classification; QoL, quality of life; reps, repetitions; RT, resistance training.

First, the prevention of skeletal myopathy or cardiac cachexia is the primary goal for this phase of exercise.^[@bibr83-1179546817751438]^ Oxidative stress is one of main pathways leading to sarcopenia and cardiac cachexia. Exercise training could modify this oxidative stress and overactivity of the ubiquitin-proteasome system thereby reversing skeletal muscle atrophy in HF in experimental animals.^[@bibr84-1179546817751438]^ These effects may lead to the improvement of cardiac cachexia, in which skeletal muscle atrophy is a consequence of protein synthesis and degradation imbalance.^[@bibr85-1179546817751438]^ Improvements in skeletal muscle function after training have been explained by corrections made to the oxidative capacity of impaired muscle, as well as to a reversal of chronic heart failure--mediated decline in skeletal muscle mass. Exercise training has also been reported to have some effects on neurohormonal factors, such as angiotensin II.^[@bibr86-1179546817751438]^ Angiotensin II was reported to be a contributing factor to skeletal muscle atrophy^[@bibr87-1179546817751438]^ so that exercise may have beneficial effects on sarcopenia through modifying these neurohormonal pathways.

Increased coordination of adaptive response to exercise is required to increase exercise capacity. Patients with severe HF generally have an exaggerated ventilator response and decreased adaptive response to exercise,^[@bibr88-1179546817751438]^ resulting in further decrease in exercise capacity. Proposed causes of the increased ventilator response to exercise include mismatching of ventilation relative to pulmonary perfusion^[@bibr89-1179546817751438]^ and exaggerated ergoreflex response originating in the exercising skeletal muscles during effort.^[@bibr90-1179546817751438]^ Indeed, there is reported to be a close association between abnormal reflex response and reduced skeletal muscle mass.^[@bibr91-1179546817751438]^ These responses can be corrected by endurance and variation in resistant training tasks through skeletal muscle reinforcement.^[@bibr92-1179546817751438]^

Exercise training has also a marked beneficial impact on vascular function. Linke et al^[@bibr93-1179546817751438]^ demonstrated the lower-limb exercise improved the systemic endothelial function in patients with HF. Anagnostakou et al reported that strength training in addition to interval cycle training had a marked impact on the improvement of vascular function in patients with HF. These improvements of vascular function would work for the amelioration of HF.^[@bibr16-1179546817751438]^

Exercise training affects physical activity as well as emotional stability.^[@bibr94-1179546817751438]^ The effect of mood may have a tremendous effect on the improvement of HF; emotional mood has a close association with autonomic balance,^[@bibr95-1179546817751438]^ and a depressed mood certainly aggravates the state of HF.^[@bibr96-1179546817751438]^ These effects can be expected more intensely in patients with advanced HF, in particular, patients with continuous inotropic infusion, who has a tendency to become depressive.^[@bibr97-1179546817751438]^ In addition, physical inactivity itself increases the risk of depression.^[@bibr98-1179546817751438]^ A gradual increase in physical activity seems to have meaningful impact during the course of HF treatment.

Moreover, exercise training may affect endothelial function and improve the flow of nutritive blood and oxygen to the skeletal muscle,^[@bibr99-1179546817751438]^ leading to a partial shifting from type II to type I muscle fibers and resulting in greater oxidative capacity.^[@bibr100-1179546817751438]^ Endothelial dysfunction had been reported to have some contributions on the worsening of HF,^[@bibr101-1179546817751438]^ which is expected to be improved by exercise training.^[@bibr102-1179546817751438]^

Conclusions {#section7-1179546817751438}
===========

In addition to increasing exercise capacity, several expected benefits result from exercise training. These effects, including the prevention of skeletal muscle atrophy and cardiac cachexia, possibly have a positive effect on the course of HF. Therefore, exercise training should be considered in patients with advanced HF with continuous inotropic infusion therapy. However, there had been little evidence about the methodology of exercise training in patients with advanced HF. The association between the effects of exercise training and the course of advanced HF should be further investigated.

**Funding:**The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan through grant-in-aid 26461103 (to E.A.).

**Declaration of conflicting interests:**The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

**Author Contributions:** EA wrote the first draft of the manuscript. MT made critical revisions and approved the final version.
